Gemtesa (Vibegron) Drug Interactions: 24 Major, 46 Moderate
Gemtesa (Vibegron) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Gemtesa. Always confirm against the full prescribing information.
83 interactions
Alfuzosin
The therapeutic efficacy of Vibegron can be decreased when used in combination with Alfuzosin.
Level 2 evidence
Amitriptyline
The therapeutic efficacy of Vibegron can be decreased when used in combination with Amitriptyline.
Level 2 evidence
Amoxapine
The therapeutic efficacy of Vibegron can be decreased when used in combination with Amoxapine.
Level 2 evidence
Aripiprazole
The therapeutic efficacy of Vibegron can be decreased when used in combination with Aripiprazole.
Level 2 evidence
Aripiprazole lauroxil
The therapeutic efficacy of Vibegron can be decreased when used in combination with Aripiprazole lauroxil.
Level 2 evidence
Asenapine
The therapeutic efficacy of Vibegron can be decreased when used in combination with Asenapine.
Level 2 evidence
Benzylpenicilloyl polylysine
Vibegron may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent.
Level 2 evidence
Brexpiprazole
The therapeutic efficacy of Vibegron can be decreased when used in combination with Brexpiprazole.
Level 2 evidence
Chlorpromazine
The therapeutic efficacy of Vibegron can be decreased when used in combination with Chlorpromazine.
Level 2 evidence
Clomipramine
The risk or severity of hypertension can be increased when Clomipramine is combined with Vibegron.
Level 2 evidence
Clozapine
The therapeutic efficacy of Vibegron can be decreased when used in combination with Clozapine.
Level 2 evidence
Desipramine
The risk or severity of hypertension can be increased when Desipramine is combined with Vibegron.
Level 2 evidence
Enter your NPI to unlock 24 major interactions for Gemtesa
Gemtesa (Vibegron) has 83 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Gemtesa (Vibegron) has 24 major, 46 moderate, and 13 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Gemtesa. Always confirm against the full prescribing information.